LIDDS AB (publ) (LIDDS.ST)
LIDDS.ST Stock Price Chart
Explore LIDDS AB (publ) interactive price chart. Choose custom timeframes to analyze LIDDS.ST price movements and trends.
LIDDS.ST Company Profile
Discover essential business fundamentals and corporate details for LIDDS AB (publ) (LIDDS.ST) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
31 Jul 2014
Employees
1.00
Website
https://www.liddspharma.comCEO
Mats Wiking
Description
LIDDS AB (publ), a pharmaceutical company, develops and sells pharmaceutical products for cancer and other diseases in Sweden. It is developing various drugs, such as NZ-2HOF to treat prostate cancer; NZ-DTX to treat breast, prostate, head, neck, stomach, and lung cancer; NZ-DOX for the treatment of solid tumors; NZ-IO, an immunotherapy; NZ-STING for the treatment of immuno-oncology; and NZ-TLR9 for enhancing cancer immunotherapies. LIDDS AB (publ) has a collaboration agreement with PharmIdea SIA to focus on anti-cancer drugs and sterile formulations. The company is based in Uppsala, Sweden.
LIDDS.ST Financial Timeline
Browse a chronological timeline of LIDDS AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 27 May 2026
Upcoming earnings on 18 Feb 2026
Upcoming earnings on 20 Nov 2025
Earnings released on 28 Aug 2025
Earnings released on 28 May 2025
EPS came in at -kr 0.01 .
Earnings released on 20 Feb 2025
EPS came in at -kr 0.01 .
Earnings released on 21 Nov 2024
EPS came in at -kr 0.01 , while revenue for the quarter reached kr 14.00K .
Earnings released on 28 Aug 2024
EPS came in at -kr 0.02 , while revenue for the quarter reached -kr 5.00K .
Earnings released on 30 May 2024
EPS came in at -kr 0.01 , while revenue for the quarter reached kr 32.00K .
Earnings released on 22 Feb 2024
EPS came in at -kr 0.27 .
Earnings released on 28 Nov 2023
EPS came in at -kr 0.07 .
Earnings released on 31 Aug 2023
EPS came in at -kr 0.11 .
Earnings released on 29 May 2023
EPS came in at -kr 0.18 .
Earnings released on 13 Mar 2023
EPS came in at -kr 0.25 , while revenue for the quarter reached -kr 110.00K , missing expectations by -119.71%.
Stock split effective on 17 Jan 2023
Shares were split 43 : 40 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 28 Nov 2022
EPS came in at -kr 0.22 , while revenue for the quarter reached kr 1.19M .
Earnings released on 25 Aug 2022
EPS came in at -kr 0.27 , while revenue for the quarter reached kr 255.00K .
Earnings released on 24 May 2022
EPS came in at -kr 0.27 , while revenue for the quarter reached kr 558.00K .
Earnings released on 23 Feb 2022
EPS came in at -kr 0.22 , while revenue for the quarter reached kr 2.37M .
Earnings released on 22 Nov 2021
EPS came in at -kr 0.24 , while revenue for the quarter reached kr 430.00K .
Earnings released on 26 Aug 2021
EPS came in at -kr 0.30 , while revenue for the quarter reached kr 149.00K .
Earnings released on 17 May 2021
EPS came in at -kr 0.34 , while revenue for the quarter reached kr 606.00K .
Earnings released on 25 Feb 2021
EPS came in at -kr 0.43 , while revenue for the quarter reached kr 345.00K .
Earnings released on 19 Nov 2020
EPS came in at -kr 0.23 .
LIDDS.ST Stock Performance
Access detailed LIDDS.ST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.